Prognostic Role of Pre-Treatment Body Composition Parameters in Patients Undergoing First-Line Immunotherapy for Metastatic Renal Cell Carcinoma.

Sangmin LeeJae-Hun KimWan Song Hyun Hwan SungHwang Gyun JeonByong Chang JeongSeong Il SeoSeong Soo JeonSe Hoon ParkJi Hyun Lee Jiwoong YuMinyong Kang

Published in: Cancer management and research (2024)

High SFI predicts favorable OS in patients with mRCC receiving first-line ICI-based therapy, especially patients treated with ipilimumab + nivolumab displayed a significant association between high SFI and favorable PFS and OS.

Keyphrases

body composition
metastatic renal cell carcinoma
patients undergoing
resistance training
bone mineral density
stem cells
replacement therapy
smoking cessation